THOMAS KOSTEN to Antidepressive Agents
This is a "connection" page, showing publications THOMAS KOSTEN has written about Antidepressive Agents.
Connection Strength
0.469
-
Efficacy and Safety of Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants: A Phase 3 Randomized Controlled Trial. J Clin Psychiatry. 2024 Jun 17; 85(3).
Score: 0.178
-
The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review. J Affect Disord. 2020 03 01; 264:123-129.
Score: 0.130
-
Depression and stimulant dependence: neurobiology and pharmacotherapy. J Nerv Ment Dis. 1998 Dec; 186(12):737-45.
Score: 0.121
-
Neurobiological adaptations to psychostimulants and opiates as a basis of treatment development. Ann N Y Acad Sci. 2000; 909:51-87.
Score: 0.033
-
Pharmacotherapy for opioid and cocaine abuse. Med Clin North Am. 1997 Jul; 81(4):909-25.
Score: 0.007